Chemoinformaics analysis of DI-(P-HYDROXY-CIS-STYRYL)-METHANE
| Molecular Weight | 252.313 | nRot | 4 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 14 |
| Exact Molecular Weight | 252.115 | nRing | 2 |
| Solubility: LogS | -3.349 | nHRing | 0 |
| Solubility: LogP | 3.915 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 40.6627 |
| nHD | 2 | BPOL | 16.0513 |
| QED | 0.855 |
| Synth | 2.222 |
| Natural Product Likeliness | 0.664 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.872 |
| Pgp-sub | 0.015 |
| HIA | 0.011 |
| CACO-2 | -4.713 |
| MDCK | 0.0000158 |
| BBB | 0.172 |
| PPB | 0.983534 |
| VDSS | 1.169 |
| FU | 0.0113897 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.823 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.58 |
| CYP2c9-sub | 0.965 |
| CYP2d6-inh | 0.628 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.899 |
| CYP3a4-sub | 0.299 |
| CL | 16.2 |
| T12 | 0.93 |
| hERG | 0.356 |
| Ames | 0.03 |
| ROA | 0.116 |
| SkinSen | 0.977 |
| Carcinogencity | 0.34 |
| EI | 0.984 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.423 |
| Antiviral | No |
| Prediction | 0.758421 |